NAVAN Technologies
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
733 Industrial Rd, San Carlos, Californi...Phone Number
(650) 491-9632Website
www.navanbio.comRevenue
<$5 MillionIndustry
About NAVAN Technologies
NAVAN Technologies, Inc. specializes in advanced cell and gene therapy solutions through its innovative NanoStraw Technology, which allows for non-perturbative and precise delivery of various cargo types into primary cell types while maintaining cell health. The company aims to address the challenges of cell viability and manufacturing in vector-based therapies, collaborating with strategic partners to develop treatments across a wide range of indications. NAVAN's technology enhances cellular access, significantly improving the efficacy of therapy development and reducing the difficulties associated with traditional methods. Located in San Carlos, CA, NAVAN is part of the JLABS portfolio, focusing on accelerating advancements in cell-gene therapies and regenerative medicine.Explore more
SIC Code 87,873NAICS Code 54,541Show moreNAVAN Technologies Org Chart
Compare Similar Companies to NAVAN Technologies
Compare insights from companies similar to NAVAN Technologies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
NAVAN Technologies Tech Stack
A closer look at the technologies used by NAVAN Technologies
See more technologies
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding NAVAN Technologies
Sign Up For FreeTo access detailed company insights
NAVAN Technologies, Inc. specializes in advanced cell and gene therapy solutions through its innovative NanoStraw Technology, which allows for non-perturbative and precise delivery of various cargo types into primary cell types while maintaining cell health. The company aims to address the challenges of cell viability and manufacturing in vector-ba... Read More
